{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:06:03Z","timestamp":1791068763698,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T00:00:00Z","timestamp":1649721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s13311-022-01233-8","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T13:03:08Z","timestamp":1649768588000},"page":"1085-1101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis"],"prefix":"10.1016","volume":"19","author":[{"given":"Wenxue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshan","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Pasternack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garcia-Montojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-5855","authenticated-orcid":false,"given":"Avindra","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-022-01233-8_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","article-title":"ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration","volume":"73","author":"Ravits","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1073\/pnas.36.6.344","article-title":"The origin and behavior of mutable loci in maize","volume":"36","author":"McClintock","year":"1950","journal-title":"Proc Natl Acad Sci"},{"key":"10.1007\/s13311-022-01233-8_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"10.1007\/s13311-022-01233-8_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1101\/gr.5826307","article-title":"The evolutionary history of human DNA transposons: Evidence for intense activity in the primate lineage","volume":"17","author":"Pace","year":"2007","journal-title":"Genome Res"},{"key":"10.1007\/s13311-022-01233-8_bib5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0092-8674(85)90197-7","article-title":"Ty elements transpose through an RNA intermediate","volume":"40","author":"Boeke","year":"1985","journal-title":"Cell"},{"key":"10.1007\/s13311-022-01233-8_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1759-8753-1-15","article-title":"Non-long terminal repeat (non-LTR) retrotransposons: mechanisms, recent developments, and unanswered questions","volume":"1","author":"Han","year":"2010","journal-title":"Mob DNA"},{"key":"10.1007\/s13311-022-01233-8_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/gb-2011-12-12-236","article-title":"Alu elements: know the SINEs","volume":"12","author":"Deininger","year":"2011","journal-title":"Genome Biol"},{"key":"10.1007\/s13311-022-01233-8_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gde.2012.02.006","article-title":"Active human retrotransposons: variation and disease","volume":"22","author":"Hancks","year":"2012","journal-title":"Curr Opin Genet Dev"},{"key":"10.1007\/s13311-022-01233-8_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tig.2007.02.006","article-title":"Which transposable elements are active in the human genome?","volume":"23","author":"Mills","year":"2007","journal-title":"Trends in genetics : TIG"},{"key":"10.1007\/s13311-022-01233-8_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrmicro2783","article-title":"Studies of endogenous retroviruses reveal a continuing evolutionary saga","volume":"10","author":"Stoye","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1007\/s13311-022-01233-8_bib11","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/nar\/12.5.2273","article-title":"'Solo' large terminal repeats (LTR) of an endogenous retrovirus-like gene family (VL30) in the mouse genome","volume":"12","author":"Rotman","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-022-01233-8_bib12","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1101\/gr.132102","article-title":"Genome size reduction through illegitimate recombination counteracts genome expansion in Arabidopsis","volume":"12","author":"Devos","year":"2002","journal-title":"Genome Res"},{"key":"10.1007\/s13311-022-01233-8_bib13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0960-9822(01)00553-X","article-title":"Endogenous retroviruses: Still active after all these years?","volume":"11","author":"Stoye","year":"2001","journal-title":"Curr Biol"},{"key":"10.1007\/s13311-022-01233-8_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.genet.42.110807.091501","article-title":"Effects of retroviruses on host genome function","volume":"42","author":"Jern","year":"2008","journal-title":"Annu Rev Genet"},{"key":"10.1007\/s13311-022-01233-8_bib15","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.3389\/fmicb.2020.01690","article-title":"Human Endogenous Retrovirus K (HML-2) in Health and Disease","volume":"11","author":"Xue","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1007\/s13311-022-01233-8_bib16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/jvi.65.3.1273-1285.1991","article-title":"Virological events leading to spontaneous AKR thymomas","volume":"65","author":"Stoye","year":"1991","journal-title":"J Virol"},{"key":"10.1007\/s13311-022-01233-8_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-4690-8-90","article-title":"Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses","volume":"8","author":"Subramanian","year":"2011","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-022-01233-8_bib18","doi-asserted-by":"crossref","first-page":"E2326","DOI":"10.1073\/pnas.1602336113","article-title":"Discovery of unfixed endogenous retrovirus insertions in diverse human populations","volume":"113","author":"Wildschutte","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01233-8_bib19","doi-asserted-by":"crossref","first-page":"10008","DOI":"10.1128\/JVI.01016-08","article-title":"Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21","volume":"82","author":"Ruprecht","year":"2008","journal-title":"J Virol"},{"key":"10.1007\/s13311-022-01233-8_bib20","doi-asserted-by":"crossref","first-page":"17842","DOI":"10.1073\/pnas.2002427117","article-title":"Regulation of stem cell function and neuronal differentiation by HERV-K via mTOR pathway","volume":"117","author":"Wang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1007\/s13311-022-01233-8_bib21","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.1038\/s41598-021-92223-x","article-title":"SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression","volume":"11","author":"Doucet-O'Hare","year":"2021","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-022-01233-8_bib22","doi-asserted-by":"crossref","unstructured":"Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7:307ra153.","DOI":"10.1126\/scitranslmed.aac8201"},{"key":"10.1007\/s13311-022-01233-8_bib23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ana.22149","article-title":"Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis","volume":"69","author":"Douville","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13024-018-0275-3","article-title":"Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins","volume":"13","author":"Mayer","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.1007\/s13311-022-01233-8_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-019-0698-2","article-title":"Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis","volume":"7","author":"Garson","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01233-8_bib26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41576-019-0165-8","article-title":"Transposable elements in human genetic disease","volume":"20","author":"Payer","year":"2019","journal-title":"Nat Rev Genet"},{"key":"10.1007\/s13311-022-01233-8_bib27","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41467-021-21808-x","article-title":"Identifying transposable element expression dynamics and heterogeneity during development at the single-cell level with a processing pipeline scTE","volume":"12","author":"He","year":"2021","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-022-01233-8_bib28","first-page":"3593","article-title":"TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets","volume":"31","author":"Jin","year":"2015","journal-title":"Bioinformatics (Oxford, England)"},{"key":"10.1007\/s13311-022-01233-8_bib29","doi-asserted-by":"crossref","first-page":"e1006564","DOI":"10.1371\/journal.pcbi.1006564","article-title":"A computational framework to assess genome-wide distribution of polymorphic human endogenous retrovirus-K In human populations","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"10.1007\/s13311-022-01233-8_bib30","doi-asserted-by":"crossref","unstructured":"Tam OH, Rozhkov NV, Shaw R, Kim D, Hubbard I, Fennessey S, Propp N, Consortium NA, Fagegaltier D, Harris BT, Ostrow LW, Phatnani H, Ravits J, Dubnau J, Gale Hammell M. Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia. Cell Rep. 2019;29:1164\u20131177 e5.","DOI":"10.1016\/j.celrep.2019.09.066"},{"key":"10.1007\/s13311-022-01233-8_bib31","first-page":"449","article-title":"Study of the Etiology of Amyotrophic Lateral Sclerosis","volume":"29","author":"Zilber","year":"1963","journal-title":"Bull World Health Organ"},{"key":"10.1007\/s13311-022-01233-8_bib32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1126\/science.147.3662.1114","article-title":"Soviet Search for Viruses That Cause Chronic Neurologic Diseases in the U.S.S.R","volume":"147","author":"Brody","year":"1965","journal-title":"Science"},{"key":"10.1007\/s13311-022-01233-8_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jcp.25.Suppl_6.132","article-title":"Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology","volume":"6","author":"Gibbs","year":"1972","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"10.1007\/s13311-022-01233-8_bib34","first-page":"343","article-title":"An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson's disease","volume":"36","author":"Gibbs","year":"1982","journal-title":"Adv Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib35","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/trf.14145","article-title":"Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk","volume":"57","author":"Crowder","year":"2017","journal-title":"Transfusion"},{"key":"10.1007\/s13311-022-01233-8_bib36","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2016.5.FOCUS15126","article-title":"Human prion diseases: surgical lessons learned from iatrogenic prion transmission","volume":"41","author":"Bonda","year":"2016","journal-title":"Neurosurg Focus"},{"key":"10.1007\/s13311-022-01233-8_bib37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/ICO.0b013e31816a628d","article-title":"Creutzfeldt-Jakob disease in recipients of corneal transplants","volume":"27","author":"Maddox","year":"2008","journal-title":"Cornea"},{"key":"10.1007\/s13311-022-01233-8_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-021-01247-x","article-title":"Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients","volume":"9","author":"Douet","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01233-8_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"key":"10.1007\/s13311-022-01233-8_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-017-1703-0","article-title":"Amyloid-beta accumulation in the CNS in human growth hormone recipients in the UK","volume":"134","author":"Ritchie","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1007\/s13311-022-01233-8_bib41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-017-0503-z","article-title":"Iatrogenic Creutzfeldt-Jakob disease with Amyloid-beta pathology: an international study","volume":"6","author":"Cali","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1007\/s13311-022-01233-8_bib42","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","article-title":"Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone","volume":"70","author":"Irwin","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1212\/WNL.37.7.1211","article-title":"Pituitary growth hormone from human cadavers: neurologic disease in ten recipients","volume":"37","author":"Rappaport","year":"1987","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib44","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000391382","article-title":"Non-oncogenic infectious agents associated with experimental tumors","volume":"7","author":"Stansly","year":"1965","journal-title":"Prog Exp Tumor Res"},{"key":"10.1007\/s13311-022-01233-8_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0065-230X(08)60068-8","article-title":"Retroviruses and wild mice: an historical and personal perspective","volume":"65","author":"Gardner","year":"1994","journal-title":"Adv Cancer Res"},{"key":"10.1007\/s13311-022-01233-8_bib46","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.86.10.3896","article-title":"Retrovirus-induced murine motor neuron disease: mapping the determinant of spongiform degeneration within the envelope gene","volume":"86","author":"Paquette","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01233-8_bib47","doi-asserted-by":"crossref","first-page":"8818","DOI":"10.1073\/pnas.82.24.8818","article-title":"Retrovirus-induced spongiform encephalopathy: the 3'-end long terminal repeat-containing viral sequences influence the incidence of the disease and the specificity of the neurological syndrome","volume":"82","author":"DesGroseillers","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1007\/s13311-022-01233-8_bib48","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fnins.2019.01166","article-title":"Astrocyte Infection Is Required for Retrovirus-Induced Spongiform Neurodegeneration Despite Suppressed Viral Protein Expression","volume":"13","author":"Cardona","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1007\/s13311-022-01233-8_bib49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/jn.00227.2014","article-title":"Postinhibitory rebound neurons and networks are disrupted in retrovirus-induced spongiform neurodegeneration","volume":"112","author":"Li","year":"2014","journal-title":"J Neurophysiol"},{"issue":"Suppl 2","key":"10.1007\/s13311-022-01233-8_bib50","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1086\/344528","article-title":"Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia","volume":"186","author":"Nath","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1007\/s13311-022-01233-8_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1084\/jem.142.2.483","article-title":"RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients","volume":"142","author":"Viola","year":"1975","journal-title":"J Exp Med"},{"key":"10.1007\/s13311-022-01233-8_bib52","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ana.410080612","article-title":"Amyotrophic lateral sclerosis among Chamorro migrants from Guam","volume":"8","author":"Garruto","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib53","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/01.wnl.0000297552.13219.b4","article-title":"Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate","volume":"70","author":"McCormick","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1096-9071(200008)61:4<527::AID-JMV17>3.0.CO;2-A","article-title":"Detection of reverse transcriptase activity in the serum of patients with motor neurone disease","volume":"61","author":"Andrews","year":"2000","journal-title":"J Med Virol"},{"key":"10.1007\/s13311-022-01233-8_bib55","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.wnl.0000263188.77797.99","article-title":"A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS","volume":"68","author":"MacGowan","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib56","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1212\/01.WNL.0000150899.76130.71","article-title":"Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives","volume":"64","author":"Steele","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/17482960902835988","article-title":"No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR","volume":"11","author":"Kim","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1007\/s13311-022-01233-8_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-021-00060-w","article-title":"Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia","volume":"1","author":"Phan","year":"2021","journal-title":"Communications Medicine"},{"key":"10.1007\/s13311-022-01233-8_bib59","article-title":"Human endogenous retrovirus K (HERV-K) env in neuronal extracellular vesicles: a new biomarker of motor neuron disease","author":"Li","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1007\/s13311-022-01233-8_bib60","first-page":"S213","article-title":"Neurotoxic Properties of Human Endogenous Retrovirus-K Envelope Protein and Detection in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis","volume":"90","author":"Steiner","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib61","doi-asserted-by":"crossref","unstructured":"Curzio DD, Gurm M, Turnbull M, Nadeau MJ, Meek B, Rempel JD, Fineblit S, Jonasson M, Hebert S, Ferguson-Parry J, Douville RN. Pro-Inflammatory Signaling Upregulates a Neurotoxic Conotoxin-Like Protein Encrypted Within Human Endogenous Retrovirus-K. Cells. 2020;9.","DOI":"10.3390\/cells9071584"},{"key":"10.1007\/s13311-022-01233-8_bib62","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/ene.13648","article-title":"Humoral immunity response to human endogenous retroviruses K\/W differentiates between amyotrophic lateral sclerosis and other neurological diseases","volume":"25","author":"Arru","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib63","doi-asserted-by":"crossref","unstructured":"Simula ER, Arru G, Zarbo IR, Solla P, Sechi LA. TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients. Viruses. 2021;13.","DOI":"10.3390\/v13112301"},{"key":"10.1007\/s13311-022-01233-8_bib64","doi-asserted-by":"crossref","unstructured":"Arru G, Galleri G, Deiana GA, Zarbo IR, Sechi E, Bo M, Cadoni MPL, Corda DG, Frau C, Simula ER, Manca MA, Galistu F, Solla P, Manetti R, Sechi GP, Sechi LA. 2021. HERV-K Modulates the Immune Response in ALS Patients. Microorganisms 9.","DOI":"10.3390\/microorganisms9081784"},{"key":"10.1007\/s13311-022-01233-8_bib65","doi-asserted-by":"crossref","unstructured":"Dembny P, Newman AG, Singh M, Hinz M, Szczepek M, Kruger C, Adalbert R, Dzaye O, Trimbuch T, Wallach T, Kleinau G, Derkow K, Richard BC, Schipke C, Scheidereit C, Stachelscheid H, Golenbock D, Peters O, Coleman M, Heppner FL, Scheerer P, Tarabykin V, Ruprecht K, Izsvak Z, Mayer J, Lehnardt S. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors. JCI Insight. 2020;5.","DOI":"10.1172\/jci.insight.131093"},{"key":"10.1007\/s13311-022-01233-8_bib66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-10-16","article-title":"Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?","volume":"10","author":"Manghera","year":"2013","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-022-01233-8_bib67","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/JVI.79.2.876-883.2005","article-title":"CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2)","volume":"79","author":"Lavie","year":"2005","journal-title":"J Virol"},{"key":"10.1007\/s13311-022-01233-8_bib68","doi-asserted-by":"crossref","unstructured":"Khodosevich K, Lebedev Y, Sverdlov ED. Large-scale determination of the methylation status of retrotransposons in different tissues using a methylation tags approach. Nucleic Acids Res. 2004;32:e31.","DOI":"10.1093\/nar\/gnh035"},{"key":"10.1007\/s13311-022-01233-8_bib69","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s00018-008-8494-3","article-title":"Keeping active endogenous retroviral-like elements in check: the epigenetic perspective","volume":"65","author":"Maksakova","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1007\/s13311-022-01233-8_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12977-016-0242-4","article-title":"Human endogenous retrovirus (HERV) expression is not induced by treatment with the histone deacetylase (HDAC) inhibitors in cellular models of HIV-1 latency","volume":"13","author":"Hurst","year":"2016","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-022-01233-8_bib71","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/1040841X.2018.1501345","article-title":"Human endogenous retrovirus-K (HML-2): a comprehensive review","volume":"44","author":"Garcia-Montojo","year":"2018","journal-title":"Crit Rev Microbiol"},{"key":"10.1007\/s13311-022-01233-8_bib72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12640-015-9573-5","article-title":"Bcl11b: A New Piece to the Complex Puzzle of Amyotrophic Lateral Sclerosis Neuropathogenesis?","volume":"29","author":"Lennon","year":"2016","journal-title":"Neurotox Res"},{"key":"10.1007\/s13311-022-01233-8_bib73","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1128\/JVI.00556-14","article-title":"Regulation of the HERV-K (HML-2) transcriptome by the HIV-1 Tat protein","volume":"88","author":"Gonzalez-Hernandez","year":"2014","journal-title":"J Virol"},{"key":"10.1007\/s13311-022-01233-8_bib74","doi-asserted-by":"crossref","first-page":"14283","DOI":"10.1038\/s41598-021-93742-3","article-title":"A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex","volume":"11","author":"Jones","year":"2021","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-022-01233-8_bib75","doi-asserted-by":"crossref","unstructured":"Krug L, Chatterjee N, Borges-Monroy R, Hearn S, Liao WW, Morrill K, Prazak L, Rozhkov N, Theodorou D, Hammell M, Dubnau J. Retrotransposon activation contributes to neurodegeneration in a Drosophila TDP-43 model of ALS. PLoS Genet. 2017;13:e1006635.","DOI":"10.1371\/journal.pgen.1006635"},{"key":"10.1007\/s13311-022-01233-8_bib76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12915-020-00816-1","article-title":"TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity","volume":"18","author":"Romano","year":"2020","journal-title":"BMC Biol"},{"key":"10.1007\/s13311-022-01233-8_bib77","doi-asserted-by":"crossref","unstructured":"Keegan RM, Talbot LR, Chang YH, Metzger MJ, Dubnau J. Intercellular viral spread and intracellular transposition of Drosophila gypsy. PLoS Genet. 2021;17:e1009535.","DOI":"10.1371\/journal.pgen.1009535"},{"key":"10.1007\/s13311-022-01233-8_bib78","doi-asserted-by":"crossref","unstructured":"Li W, Jin Y, Prazak L, Hammell M, Dubnau J. Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One. 2012;7:e44099.","DOI":"10.1371\/journal.pone.0044099"},{"key":"10.1007\/s13311-022-01233-8_bib79","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.57.6.995","article-title":"Reversible ALS-like disorder in HIV infection","volume":"57","author":"Moulignier","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib80","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM198508013130511","article-title":"Isolation of LAV\/HTLV-III from a patient with amyotrophic lateral sclerosis","volume":"313","author":"Hoffman","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-022-01233-8_bib81","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1212\/WNL.57.6.1094","article-title":"An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy","volume":"57","author":"MacGowan","year":"2001","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2005.09.005","article-title":"ALS syndrome in patients with HIV-1 infection","volume":"240","author":"Verma","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-022-01233-8_bib83","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2004.06.006","article-title":"HIV-1 clade-C-associated \"ALS\"-like disorder: first report from India","volume":"224","author":"Sinha","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-022-01233-8_bib84","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/2325957414535254","article-title":"Amyotrophic lateral sclerosis-like presentation in a HIV-positive patient","volume":"13","author":"Anand","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1007\/s13311-022-01233-8_bib85","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000511203","article-title":"ALS-Like Disorder in Three HIV-Positive Patients: Case Series","volume":"13","author":"Satin","year":"2021","journal-title":"Case Rep Neurol"},{"key":"10.1007\/s13311-022-01233-8_bib86","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","article-title":"HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy","volume":"87","author":"Bowen","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib87","doi-asserted-by":"crossref","unstructured":"Bogoch, II, Wilson MR, Chad DA, Venna N. Acute lower motor neuron syndrome and spinal cord gray matter hyperintensities in HIV infection. Neurol Neuroimmunol Neuroinflamm. 2015;2:e113.","DOI":"10.1212\/NXI.0000000000000113"},{"key":"10.1007\/s13311-022-01233-8_bib88","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.4081\/ni.2015.5885","article-title":"Amyotrophic Lateral Sclerosis: New Perpectives and Update","volume":"7","author":"Orsini","year":"2015","journal-title":"Neurol Int"},{"key":"10.1007\/s13311-022-01233-8_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.antiviral.2013.05.006","article-title":"Retroviruses and amyotrophic lateral sclerosis","volume":"99","author":"Alfahad","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1007\/s13311-022-01233-8_bib90","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2018.12.030","article-title":"A comparative study of motor neuron disease in HIV-infected and HIV-uninfected patients","volume":"397","author":"Moodley","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-022-01233-8_bib91","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/17482961003610853","article-title":"The sex ratio in amyotrophic lateral sclerosis: A population based study","volume":"11","author":"Manjaly","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"key":"10.1007\/s13311-022-01233-8_bib92","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11908-014-0459-0","article-title":"Update on Neurological Manifestations of HTLV-1 Infection","volume":"17","author":"Araujo","year":"2015","journal-title":"Curr Infect Dis Rep"},{"key":"10.1007\/s13311-022-01233-8_bib93","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/01.wnl.0000180962.47653.5e","article-title":"ALS syndrome in HTLV-I infection","volume":"65","author":"Silva","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib94","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/13550280009091955","article-title":"HTLV-I-associated myelopathy (HAM)\/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations","volume":"6","author":"Matsuzaki","year":"2000","journal-title":"J Neurovirol"},{"key":"10.1007\/s13311-022-01233-8_bib95","first-page":"433","article-title":"Paraplegia associated with HTLV 1 in Martinique. Study of 271 cases including 70 with neuromuscular involvement","volume":"86","author":"Smadja","year":"1993","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1007\/s13311-022-01233-8_bib96","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2169\/internalmedicine.54.3660","article-title":"Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms","volume":"54","author":"Ando","year":"2015","journal-title":"Intern Med"},{"key":"10.1007\/s13311-022-01233-8_bib97","doi-asserted-by":"crossref","unstructured":"Khosa SW, A.; Mishra, S.K. Rare Case of Human T-lymphotropic Virus-1 (HTLV-1) with Amyotrophic lateral sclerosis. Neurology. 2019;92:P4.9\u2013003.","DOI":"10.1212\/WNL.92.15_supplement.P4.9-003"},{"issue":"Suppl","key":"10.1007\/s13311-022-01233-8_bib98","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0022-510X(95)00086-H","article-title":"HTLV tax-rex DNA and antibodies in idiopathic amyotrophic lateral sclerosis","volume":"129","author":"Ferrante","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-022-01233-8_bib99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-510X(97)00199-8","article-title":"Lack of evidence for HTLV tax-rex DNA in motor neurone disease","volume":"153","author":"Andrews","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-022-01233-8_bib100","first-page":"1","article-title":"Human spuma retrovirus antibodies in amyotrophic lateral sclerosis","volume":"1","author":"Westarp","year":"1992","journal-title":"Neurology Psychiatry Brain Res"},{"key":"10.1007\/s13311-022-01233-8_bib101","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00001756-199306000-00056","article-title":"Antiretroviral therapy in sporadic adult amyotrophic lateral sclerosis","volume":"4","author":"Westarp","year":"1993","journal-title":"NeuroReport"},{"key":"10.1007\/s13311-022-01233-8_bib102","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0196-9781(94)90004-3","article-title":"Retroviral synthetic peptide serum antibodies in human sporadic amyotrophic lateral sclerosis","volume":"15","author":"Westarp","year":"1994","journal-title":"Peptides"},{"key":"10.1007\/s13311-022-01233-8_bib103","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1096-9071(199603)48:3<222::AID-JMV2>3.0.CO;2-A","article-title":"Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis","volume":"48","author":"Rosener","year":"1996","journal-title":"J Med Virol"},{"key":"10.1007\/s13311-022-01233-8_bib104","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1158\/1078-0432.CCR-17-0001","article-title":"Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth","volume":"23","author":"Li","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1007\/s13311-022-01233-8_bib105","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.onc.1206241","article-title":"Quantitation of HERV-K env gene expression and splicing in human breast cancer","volume":"22","author":"Wang-Johanning","year":"2003","journal-title":"Oncogene"},{"key":"10.1007\/s13311-022-01233-8_bib106","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1177\/1947601911431841","article-title":"Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer","volume":"2","author":"Zhao","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1007\/s13311-022-01233-8_bib107","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.28389","article-title":"Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer","volume":"134","author":"Wang-Johanning","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1007\/s13311-022-01233-8_bib108","doi-asserted-by":"crossref","unstructured":"Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ, Wang-Johanning F. Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. Oncoimmunology. 2015;4:e1047582.","DOI":"10.1080\/2162402X.2015.1047582"},{"key":"10.1007\/s13311-022-01233-8_bib109","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/095632020101200202","article-title":"Differential susceptibility of retroviruses to nucleoside analogues","volume":"12","author":"Rosenblum","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"10.1007\/s13311-022-01233-8_bib110","doi-asserted-by":"crossref","first-page":"e01309","DOI":"10.1128\/JVI.01309-17","article-title":"Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors","volume":"91","author":"Contreras-Galindo","year":"2017","journal-title":"J Virol"},{"key":"10.1007\/s13311-022-01233-8_bib111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12977-017-0347-4","article-title":"Inhibition of human endogenous retrovirus-K by antiretroviral drugs","volume":"14","author":"Tyagi","year":"2017","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-022-01233-8_bib112","doi-asserted-by":"crossref","first-page":"17137","DOI":"10.1021\/bi9818927","article-title":"Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?","volume":"37","author":"Towler","year":"1998","journal-title":"Biochemistry"},{"key":"10.1007\/s13311-022-01233-8_bib113","doi-asserted-by":"crossref","first-page":"16674","DOI":"10.1074\/jbc.M008763200","article-title":"Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays","volume":"276","author":"Kuhelj","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-022-01233-8_bib114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12977-017-0347-4","article-title":"Inhibition of human endogenous retrovirus-K replication by antiretroviral drugs","volume":"14","author":"Tyagi","year":"2017","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-022-01233-8_bib115","first-page":"2587094","article-title":"Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals","volume":"2016","author":"Nwogu","year":"2016","journal-title":"AIDS Res Treat"},{"key":"10.1007\/s13311-022-01233-8_bib116","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12977-017-0370-5","article-title":"Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain","volume":"14","author":"Asahchop","year":"2017","journal-title":"Retrovirology"},{"key":"10.1007\/s13311-022-01233-8_bib117","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/QAD.0000000000002628","article-title":"Antiretroviral drug concentrations in brain tissue of adult decedents","volume":"34","author":"Ferrara","year":"2020","journal-title":"AIDS"},{"key":"10.1007\/s13311-022-01233-8_bib118","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11481-019-09886-7","article-title":"CNS Neurotoxicity of Antiretrovirals","volume":"16","author":"Lanman","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1007\/s13311-022-01233-8_bib119","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01147-14","article-title":"Genomic Flexibility of Human Endogenous Retrovirus Type K","author":"Dube","year":"2014","journal-title":"J Virol"},{"key":"10.1007\/s13311-022-01233-8_bib120","doi-asserted-by":"crossref","unstructured":"Garcia-Montojo M, Fathi S, Norato G, Smith BR, Rowe DB, Kiernan MC, Vucic S, Mathers S, van Eijk RPA, Santamaria U, Rogers ML, Malaspina A, Lombardi V, Mehta PR, Westeneng HJ, van den Berg LH, Al-Chalabi A, Gold J, Nath A. Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy. J Neurol Sci. 2021;423:117358.","DOI":"10.1016\/j.jns.2021.117358"},{"key":"10.1007\/s13311-022-01233-8_bib121","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/01.WNL.0000156913.24701.72","article-title":"A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS","volume":"64","author":"Scelsa","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib122","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","article-title":"HIV-associated Motor Neuron Disease: HERV-K activation and response to Anti-Retroviral Therapy","volume":"87","author":"Bowen","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-022-01233-8_bib123","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/21678421.2019.1632899","article-title":"Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial","volume":"20","author":"Gold","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1007\/s13311-022-01233-8_bib124","article-title":"Mechanisms of viral persistence in the brain and therapeutic approaches","author":"Nath","year":"2021","journal-title":"FEBS J"},{"key":"10.1007\/s13311-022-01233-8_bib125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1741-7007-9-62","article-title":"Mobile DNA transposition in somatic cells","volume":"9","author":"Kazazian","year":"2011","journal-title":"BMC Biol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01233-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01233-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:55:10Z","timestamp":1761807310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1878747923010693"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01233-8","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01233-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The authors. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}